A carregar...
Persistent bone marrow depression following short-term treatment with temozolomide
Temozolomide (TMZ) is, in combination with radiotherapy (RT), the treatment of choice for glioblastoma multiforme. Although generally well tolerated, haematological side effects are observed in approximately 1–10% of patients receiving TMZ. We report a case of a patient who developed severe bone mar...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854153/ https://ncbi.nlm.nih.gov/pubmed/27130558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-215797 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|